AGTR1 and cardiac hypertrophy: The effects of αMHC promoter-driven overexpression of AT1 are also complicated; transgenic overexpression of AT1 in cardiomyocytes, only when overexpressed at very high levels, e.g. 200-fold compared with WT mice, resulted in ventricular hypertrophy [30].